Is Ketamine Therapy Safe for Depression?

Yes, when it's delivered within a properly structured clinical protocol. Ketamine is an FDA-approved medication with decades of documented medical use, and its application for depression has been studied extensively over the past twenty years. The safety concerns worth taking seriously aren't about the medication itself but about the context in which it's used. Administered without psychological screening, medical clearance, and trained provider support, the risk profile changes significantly.

The safety profile of ketamine assisted therapy looks very different when it's delivered within a structured clinical framework, with psychological screening, medical clearance, and trained provider oversight, than it does as a standalone medication treatment.

Ketamine clinics that offer infusions without therapeutic support exist, and they represent a meaningfully different standard of care. The question to ask when evaluating any provider isn't just whether ketamine is on the menu. It's what happens before, during, and after each dosing session that determines how safe and effective the experience will be.

The research supporting ketamine assisted psychotherapy consistently points to the same conclusion: outcomes are meaningfully better and risks are meaningfully lower when dosing sessions are paired with preparation and integration rather than administered in isolation.

Ketamine isn't appropriate for everyone, and responsible providers screen carefully before recommending it. Certain medical histories, active substance use disorders, and specific psychiatric presentations make someone a poor candidate for this treatment. That's not a barrier to care. It's the screening process working as it should.

At Get Centered Wellness, KAP therapy begins with a psychological screening appointment before any dosing takes place, a step that exists specifically to ensure each client is an appropriate candidate for the treatment.

If you pass psychological screening, a medical consultation follows before any prescription is written. Both steps happen before the first dosing session. That sequence is the standard, and it's what separates a carefully managed treatment from a poorly supervised one.

Ketamine's safety record is particularly well-documented for treatment resistant depression, the clinical population where it has been most studied and where conventional antidepressants have already demonstrated limited effectiveness.

This context matters. The people most often asking about ketamine safety are those who have already been through multiple rounds of treatment that didn't work. The risk comparison for that group looks different than it does for someone who hasn't yet tried other options.

The clients who tend to ask most carefully about safety are often those who have been stuck in depression and anxiety long enough to have tried multiple treatments, and who are weighing the risks of this option against the ongoing cost of staying where they are.

During a ketamine dosing session, you may experience dissociation, altered perception, dizziness, or nausea. These effects are temporary and typically resolve within a few hours of the session ending. They're also expected parts of the experience, not signs that something has gone wrong.

Longer-term risks, including potential for dependence or cognitive effects, are associated primarily with frequent recreational use at high doses, not with supervised therapeutic protocols using lower doses across a defined number of sessions.

The body of research on ketamine for treatment resistant depression evidence and outcomes has expanded substantially over the past decade, and it offers one of the clearest clinical pictures available for understanding both efficacy and risk at the population level.

Safety is often the first question, but the one that follows closely behind it is whether ketamine therapy can help when nothing else has, and those two questions together are usually what a person is really trying to answer before deciding whether to move forward.

For people whose concerns are less about the clinical risk profile and more about the subjective experience itself, understanding what ketamine assisted therapy feels like during a dosing session tends to answer a different but equally important set of questions.

If you're weighing this option and want to understand whether you're a good candidate before making any decisions, the most useful next step is to talk with our team directly. A screening conversation costs nothing and gives you a clearer picture of whether this treatment makes sense for where you are right now.

If you're looking for ongoing trauma-focused therapy rather than a medication-assisted approach, The Center for Trauma, Stress, and Anxiety is our sister practice in Bel Air, offering specialized clinical care for adults navigating trauma, chronic stress, and anxiety.

Can ketamine make depression worse?

In some cases and under certain conditions, yes. Dissociative experiences during dosing can be destabilizing for people with certain psychiatric histories, which is exactly why psychological screening happens before treatment begins. A well-run protocol is specifically designed to identify and exclude people for whom ketamine would carry more risk than benefit. If you clear screening and complete a medical consultation, your provider has assessed that the treatment is appropriate for your specific presentation.

Is ketamine addictive if used for depression treatment?

The risk of dependence in a supervised therapeutic protocol is low and meaningfully different from recreational use. Therapeutic ketamine is administered at lower doses, across a defined and limited number of sessions, with clinical oversight at each step. Recreational ketamine use at high frequency and high doses carries a different risk profile entirely. If you have a history of substance use disorders, that will come up during screening and factor directly into whether KAP is recommended for you.